Desipramine for the treatment of 'pure' dysthymia versus 'double' depression

D. B. Marin, J. H. Kocsis, A. J. Frances, M. Parides

Research output: Contribution to journalArticlepeer-review

40 Scopus citations


The authors report results of an 8-week, open trial of desipramine in 42 patients with DSM-III-R dysthymia with a concurrent diagnosis of major depression ('double' depression) and 33 patients with dysthymia who had no other depressive diagnosis ('pure' dysthymia). Either complete or partial remission was achieved by 70% of the patients with 'pure' dysthymia. This compared favorably with but was not significantly different from results in the 'double' depression group.

Original languageEnglish (US)
Pages (from-to)1079-1080
Number of pages2
JournalAmerican Journal of Psychiatry
Issue number7
StatePublished - 1994
Externally publishedYes

ASJC Scopus subject areas

  • Psychiatry and Mental health


Dive into the research topics of 'Desipramine for the treatment of 'pure' dysthymia versus 'double' depression'. Together they form a unique fingerprint.

Cite this